SELLAS LIFE SCIENCES GROUP I (SLS) Forecast, Price Target & Analyst Ratings
NASDAQ:SLS • US81642T2096
5.365 USD
-0.17 (-3.16%)
Last: Mar 5, 2026, 11:38 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SELLAS LIFE SCIENCES GROUP I (SLS).
Forecast Snapshot
Consensus Price Target
$6.97
+ 29.92% Upside
Next Earnings Forecast
Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$0.07
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.97
Upside
+ 29.92%
From current price of $5.37 to mean target of $6.97, Based on 7 analyst forecasts
Low
$6.06
Median
$7.14
High
$7.88
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 analysts have analysed SLS and the average price target is 6.97 USD. This implies a price increase of 29.92% is expected in the next year compared to the current price of 5.365.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
SLS was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SLS.
In the previous month the buy percentage consensus was at a similar level.
SLS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-16 | Maxim Group | Maintains | Buy -> Buy |
| 2023-11-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2022-11-15 | Alliance Global Partners | Maintains | Buy |
| 2022-06-28 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-07-21 | Cantor Fitzgerald | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 18, 2026
PeriodQ4 / 2025
EPS Estimate-$0.07
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q17.94%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
7.14%
Next Earnings Summary
SLS is expected to report earnings on 3/18/2026. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.9M | 7.6M 300.00% | 1M -86.84% | 13.13M -100.00% | 21.897M | 36.656M 67.40% | 120.67M 229.20% | 296.24M 145.50% | 520.25M 75.62% | 634.81M 22.02% | |||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.98M 1.34% | -19.59M -15.37% | -31.95M -63.09% | -29.545M -18.53% | -32.466M 15.50% | -28.728M 10.22% | -43.182M -50.31% | -25.734M 40.40% | 11.177M 143.43% | 181.96M 1,527.99% | 357.61M 96.53% | 445.37M 24.54% | |
| Operating Margin | -893.68% | -257.76% | -3,195.00% | -225.02% | N/A | N/A | -197.20% | -70.21% | 9.26% | 61.42% | 68.74% | 70.16% | |
| EPS YoY % growth | N/A 91.58% | -1.33 27.25% | -2.23 -67.67% | -1.10 39.01% | -0.54 61.76% | -0.26 49.44% | -0.32 -21.13% | -0.18 45.03% | 0.11 160.58% | 1.66 1,461.90% | 3.23 95.12% | 3.93 21.56% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 17.94% | -0.07 6.21% | -0.07 3.80% | -0.08 -25.69% | -0.08 -23.08% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.509M -23.00% | -8.953M -47.67% | -9.562M -39.13% | -11.139M -57.27% | -10.98M -29.03% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
18.48%
EPS Next 5 Year
38.98%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SELLAS LIFE SCIENCES GROUP I / SLS Forecast FAQ
What is the price target for SLS stock?
7 analysts have analysed SLS and the average price target is 6.97 USD. This implies a price increase of 29.92% is expected in the next year compared to the current price of 5.365.
Can you provide the upcoming earnings date for SELLAS LIFE SCIENCES GROUP I?
SELLAS LIFE SCIENCES GROUP I (SLS) will report earnings on 2026-03-18, after the market close.
What are the consensus estimates for SELLAS LIFE SCIENCES GROUP I (SLS) next earnings?
The consensus EPS estimate for the next earnings of SELLAS LIFE SCIENCES GROUP I (SLS) is -0.07 USD and the consensus revenue estimate is 0 USD.